Giant Eagle Pharmacy #4097 Community/Retail Pharmacy Location: 6556 N Ridge Rd, North Madison, Ohio 44057 Phone: (440) 428-6111 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of a clinical guide by the European Menopause and Andropause Society in the journal Maturitas on endometrial assessment in peri and postmenopausal women with summary recommendations.
ImmunoCellular Therapeutics announced today that clinical data from its Phase I trial of ICT-107 was accepted for publication, and is currently in the online edition of the prestigious medical journal Cancer Immunology, Immunotherapy.
Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305, made by Immune Design. Immunotherapy is a treatment option that uses a person's own immune system to fight cancer. It has several advantages over standard cancer therapies, including fewer side effects and an overall better tolerability. It tends to be most effective in patients who have smaller, localized tumors that have not spread to distant sites.
Noting the U.S. government on Thursday "unveiled a major new strategy for pushing towards achieving an 'AIDS-free generation,'" Inter Press Service writes, "The far-reaching new blueprint for what's known as the President's Emergency Plan for AIDS Relief (PEPFAR) is being widely lauded, yet little attention has been given to a document, published in October, that stipulates how new PEPFAR funding can be used."
ImmBio (Immunobiology Ltd), a biopharmaceutical company developing innovative vaccines against serious infectious diseases, today announced that the UK government-backed Biomedical Catalyst has awarded the company approximately £0.2 million ($0.3 million) to support pre-clinical development of its pneumococcal vaccine, PnuBioVax™, which targets a wide range of strains of the bacteria.
› Verified 5 days ago